MDxHealth is trading 5.21% up at $0.78, with no clear catalyst identified.
- No new company announcement dated August 25, 2026, appears on MDxHealth’s press-release page.
- Its latest listed release, dated August 13, reported second-quarter revenue growth of 16% to $27.2 million, without explicitly linking the news to the stock move.
- Broader markets are modestly higher.